Is widespread screening for hepatitis C justified? Several organisations have recommended greatly expanded screening for hepatitis C infection. Ronald Koretz and colleagues are concerned that no study has tested whether this will lead to net clinical benefit or harm in screened populations

Ronald L. Koretz, Kenneth W. Lin, John P.A. Ioannidis, Jeanne Lenzer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Article numberg7809
JournalBMJ (Online)
Volume350
DOIs
StatePublished - Jan 13 2015

ASJC Scopus subject areas

  • Medicine(all)

Cite this